Gene therapy is the forefront of novel and promising therapeutic modalities and neurology is considered the at the frontier in therapeutic areas with a rapidly evolving understanding of the biology and mechanisms of disease. This makes the development of Gene therapies for neurological disease an exciting, but risky field. This presentation will review the current state of the technologies and companies developing therapies in this field.